Cytokines, Janus Kinase Inhibitors, and Small-Molecule Therapies, Oh My!: New Inroads Into Rheumatoid Arthritis Management
| Overview / Abstract: |
Although the introduction of biologic agents has transformed treatment paradigms for rheumatoid arthritis (RA), a considerable proportion of patients do not respond sufficiently to these therapies. A potential new therapeutic alternative for these patients is small-molecule inhibitors, which offer targeted inhibition of intracellular pathways that can be achieved via oral administration. To realize the benefits of small-molecule inhibitor therapy, it is essential for clinicians to know how these agents target cytokine signaling and intracellular pathways. This activity contains three interactive modules designed to help clinicians understand the mechanisms of action of small-molecule inhibitors and to recognize how these agents fit into established RA management guidelines. |
|
Expiration |
Aug 02, 2018 |
|
Discipline(s) |
Nurse Practitioner , Physician CME, Physician Assistant CME |
|
Format |
Online |
|
Credits / Hours |
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and RedMedEd. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
|
Accreditation |
ACCME |
|
Is This Activity Certified for "Live" Credit? |
YES |
|
Presenters / Authors / Faculty |
Anisha B. Dua, MD, MPH—Program Chair Eric M. Ruderman, MD Mary Chester M. Wasko, MD |
|
Activity Specialities / Related Topics |
Education / Teaching, Family Medicine, Internal Medicine, Primary Care, Rheumatology / Arthritis |
|
Sponsors / Supporters / Grant Providers |
Support for this activity has been provided through an independent educational grant from Pfizer. |
|
Keywords / Search Terms |
RedMedEd RedMedEd, rheumatoid arthritis, RA, small-molecule inhibitors, small-molecule inhibitor therapy, clinicians, mechanisms of action, RA management guidelines, rheumatoid arthritis management guideline, cytokine signals, inflammation, biologics, Free CE, CME Free CE CME Live CE CME |
|